Accurate treatment of autoimmune disorders
Polyneuron Pharmaceuticals has raised €2.7M across 1 funding round from 2 investors, most recently a Seed round in May 2016. Based in Basel, Switzerland; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-05-01 | Seed |
| €2.7M |
| EVA Basel,ZKB - Zurcher Kantonalbank |
| View deal → |
